MIPS Project Detail:

BondTrue, LLC

BondTrue Prototype Design and Development

Back to Projects Home

Company

BondTrue, LLC

Towson

Baltimore

County

, Maryland

Founded:

2016

Website:

https://www.bondtrue.com/

Company Description:

BondTrue has developed a patented medical device that automates the process of surgical incisions and closures. The result is a fast, precise surgical wound that can be rapidly approximated and repaired. This significantly reduces surgical times and ensures excellent wound repair. Precise wound repair is associated with reduced scarring and decreased wound complications, including surgical wound infections.

MIPS Project

BondTrue Prototype Design and Development

Project #

5918.21

|

MIPS Round

61 |

Starting Date:

Feb 2018

MIPS Project Challenge:
The goal of this MIPS project is the design and development of an improved prototype, which will be used for multiple purposes, including animal trials.

Project Scope:
Working with Hugh Bruck and his team through this MIPS project, the prototype is being refined by designing within the compliance needed for proper interaction between the surgeon and patient. Designs are being precisely fabricated using 3D-printing and laser-cutting to allow for rapid product realization and characterization of performance. Cost analysis and re-design of the BondTrue prototype for injection molding is also being pursued for commercialization of the final product.

Collaborating with Hugh Bruck and his talented team of researchers has been pivotal for BondTrue’s progress. Using cutting-edge technology, including the latest 3-D printing technology in the mechanical engineering laboratory of the University of Maryland, has greatly advanced our prototype design, enabling us to accelerate the commercialization process.

David Zachary Martin, Co-Founder and Chief Medical Officer, BondTrue

Results:

BondTrue brings mechanical precision to a surgical process historically done by hand with the naked eye. The MIPS program has enabled collaboration between surgeons and engineers at the top of their fields, resulting in innovative breakthroughs. When the project is completed, BondTrue will raise capital to bring the product to market.

We are very pleased with this award as it allows the continuation of important research on the BondTrue medical device. This project will enable us to take the next step in commercialization by utilizing cutting-edge technology at the University of Maryland. The MIPS program provides a great opportunity to advance collaborative projects in Maryland.

David Zachary Martin, Co-Founder and Chief Medical Officer, BondTrue